valganciclovir

Generic: valganciclovir hydrochloride

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name valganciclovir
Generic Name valganciclovir hydrochloride
Labeler camber pharmaceuticals, inc.
Dosage Form POWDER, FOR SOLUTION
Routes
ORAL
Active Ingredients

valganciclovir hydrochloride 50 mg/mL

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-837
Product ID 31722-837_eaad537e-d8e5-24a2-e053-2a95a90ad075
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211475
Listing Expiration 2026-12-31
Marketing Start 2022-10-04

Pharmacologic Class

Classes
cytomegalovirus nucleoside analog dna polymerase inhibitor [epc] dna polymerase inhibitors [moa] nucleoside analog antiviral [epc] nucleoside analog [ext]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722837
Hyphenated Format 31722-837

Supplemental Identifiers

RxCUI
863559
UPC
0331722837101
UNII
4P3T9QF9NZ

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name valganciclovir (source: ndc)
Generic Name valganciclovir hydrochloride (source: ndc)
Application Number ANDA211475 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/mL
source: ndc
Packaging
  • 1 BOTTLE, GLASS in 1 CARTON (31722-837-10) / 100 mL in 1 BOTTLE, GLASS
source: ndc

Packages (1)

31722-837-10 1 BOTTLE, GLASS in 1 CARTON (31722-837-10) / 100 mL in 1 BOTTLE, GLASS

Ingredients (1)

valganciclovir hydrochloride (50 mg/mL)

Linked Drug Pages (1)

VALGANCICLOVIR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "eaad537e-d8e5-24a2-e053-2a95a90ad075", "openfda": {"upc": ["0331722837101"], "unii": ["4P3T9QF9NZ"], "rxcui": ["863559"], "spl_set_id": ["28703782-9f48-4866-a32d-1604da9dee6b"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, GLASS in 1 CARTON (31722-837-10)  / 100 mL in 1 BOTTLE, GLASS", "package_ndc": "31722-837-10", "marketing_start_date": "20221004"}], "brand_name": "VALGANCICLOVIR", "product_id": "31722-837_eaad537e-d8e5-24a2-e053-2a95a90ad075", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "DNA Polymerase Inhibitors [MoA]", "Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "31722-837", "generic_name": "VALGANCICLOVIR HYDROCHLORIDE", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VALGANCICLOVIR", "active_ingredients": [{"name": "VALGANCICLOVIR HYDROCHLORIDE", "strength": "50 mg/mL"}], "application_number": "ANDA211475", "marketing_category": "ANDA", "marketing_start_date": "20221004", "listing_expiration_date": "20261231"}